Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579306 · ClinicalTrials.gov registry record
Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study
A clinical trial of Hypertension and Stroke, sponsored by Columbia University.
- Completed
- Registry status
- 1,244
- Enrollment target
- 20
- Study locations
NCT00579306 is a study of Hypertension and Stroke that has completed, run by Columbia University. The registered enrollment target is 1,244 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (65% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT00579306, a study of Hypertension and Stroke, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 1,244 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes and who are enrolled in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.
Conditions Studied
Study Locations (20)
New York
- Columbia University Medical Center - New York
- Rochester General Hospital - Rochester
- University of Rochester Medical Center - Rochester
Arizona
- Mayo Clinic Scottsdale - Scottsdale
- University of Arizona Collage of Medicine - Tucson
California
- University of California, San Diego Medical Center - La Jolla
- Sutter Neuroscience Institute - Sacramento
Florida
- Melbourne Internal Medicine Associates - Melbourne
- University of Miami - Miami
Michigan
- Wayne State University - Detroit
- Henry Ford Health System - Detroit
Minnesota
- Hennepin County Medical Center - Minneapolis
- Mayo Clinic Rochester - Rochester
Missouri
- St. Louis University - St Louis
- St. John's Mercy Medical Center - St Louis
Alabama
- University of South Alabama - Mobile
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,244 participants |
| Start Date | 2005-06 |
| Est. Completion | 2012-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00579306
The ClinicalTrials.gov registry entry for NCT00579306 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,244 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (65% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT00579306 reports 20 study locations spanning 12 distinct geographic areas - top geographies include New York, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT00579306 about?
NCT00579306 is a clinical study titled "Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study". The goals of this trial are to determine the prognostic significance of an elevated level of inflammatory blood markers in people who have experienced small subcortical strokes and who are enrolled in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.
What is the current status of trial NCT00579306?
This trial is currently completed. The enrollment target is 1,244 participants. The study started on 2005-06. Estimated completion is 2012-07.
What conditions does trial NCT00579306 study?
This clinical trial studies the following conditions: Hypertension, Stroke.
Who is sponsoring clinical trial NCT00579306?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00579306 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.